Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)

• Main Authors: Connor O'Leary (Author), Harry Gasper (Author), Katherine B. Sahin (Author), Ming Tang (Author), Arutha Kulasinghe (Author), Mark N. Adams (Author), Derek J. Richard (Author), Ken J. O'Byrne (Author)
• Format: Book
• Published: MDPI AG, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers in non-small-cell lung cancer (NSCLC). Significant developments have taken place which highlight the differences in tumor biology that exist between the mutant and wild-type subtypes of NSCLC. Patients with advan...